# Starling Medical

> Starling Medical is a Houston-based digital health company (Y Combinator W22) building an at-home urine monitoring platform that clips onto a toilet and analyzes urine at every bathroom visit. Using spectroscopy sensors and AI, its UrinDx / StarStream device sends readings to a clinical care team that follows up when something looks off, aiming to catch recurrent UTIs, BPH flare-ups, kidney disease and diabetes complications before they become hospitalizations. The company bills through remote patient monitoring reimbursements, turning routine bathroom trips into a continuous diagnostic stream.

- **Founded:** 2019
- **Headquarters:** Houston, Texas, United States
- **Founders:** Alex Arevalos (Co-Founder & CEO), Hannah McKenney-Klepcha (Co-Founder (ex-Medtronic & J&J product engineer)), Drew Hendricks (Co-Founder)
- **Team size:** ~17 employees
- **Products:** UrinDx / StarStream, Starling smartphone app, Clinical care connection / RPM service, Pete
- **Notable:** Graduated from Y Combinator's Winter 2022 batch., Closed $3.4M seed round led by Rebel Fund (announced Jan 2023)., Described by its CEO as the world's first FDA-registered at-home urine diagnostic service.

## Products & services

- **UrinDx / StarStream** — A reusable at-home urine monitoring device that clips onto a standard toilet and uses spectroscopy sensors plus AI to analyze urine at each bathroom visit, sending readings to Starling's clinical care team nightly.
- **Starling smartphone app** — Companion app that delivers urinary health insights and trends to users' phones, supports behavioral change, and connects patients to their care team.
- **Clinical care connection / RPM service** — Nurse-supervised dashboards review urinalysis data, follow up with patients when clinical concerns arise, and manage remote patient monitoring reimbursements on behalf of physician partners.
- **Pete** — An additional product listed as 'Coming Soon' on Starling's site; details not yet public.

## Achievements

- Graduated from Y Combinator's Winter 2022 batch.
- Closed $3.4M seed round led by Rebel Fund (announced Jan 2023).
- Described by its CEO as the world's first FDA-registered at-home urine diagnostic service.
- Signed a first customer covering roughly 200,000 urology patients.
- Raised roughly $11-13M total across multiple rounds.

## Latest updates

- **2026-02** — Reported additional funding round (latest tranche ~$825K), continuing to build out its remote patient monitoring platform.
- **2023-01** — Announced $3.4M seed round and first customer deployment with a large Texas urology practice.

## Links

- Website: https://starlingmedical.com
- LinkedIn: https://www.linkedin.com/company/starling-medical
- Twitter/X: https://twitter.com/starlingmedical

---

Profile page: https://yespress.io/starling-yc-w22
Published by YesPress — https://yespress.io
Last updated: 2026-07-30